ROADMAP Project

Earlier this year, the Castleman Disease Collaborative Network reached out to the SSRA with a request to participate in a project meant to develop a well thought out plan rare disease organizations could implement to resolve the roadblocks patient organizations face in trying to gain approval for repurposing of drugs currently on the market for therapeutic use in unrelated conditions. […]

SSRA Announces Appointment of Kelly Morgan To The Board Of Directors

SSRA Leadership 2022 The Superficial Siderosis Research Alliance is pleased to share the appointment of Kelly Morgan to the SSRA Board of Directors. In addition, Ms. Morgan will serve as a member of the Grant Oversight Group and Board Member-at-Large. Following the appointment of Ms. Morgan, the Board will comprise ten directors. “We are pleased to welcome Kelly Morgan to the SSRA Board,” […]

Games, Trains, and SS Awareness

Game Train USA Driving December SS Awareness Game Train USA believes by championing local nonprofits and the causes they support is how they can give back to the community in a very big way. We’re proud to announce the Rocky Mountain Superficial Siderosis Research Alliance has been chosen as their featured charity for the month of December. We would like […]

Caregiver Respite Program

Caregiver Assistance The NORD Respite Program provides financial assistance to allow caregivers a break to attend a conference, event, or simple day out. Financial assistance is offered as a grant of up to $800 annually for those who qualify. A first-of-its-kind assistance program, this grant is designed for caregivers of someone diagnosed with a rare disorder. We all understand how […]

SSRA Announces EURORDIS Membership

The Superficial Siderosis Research Alliance is pleased to announce its membership application to EURORDIS, a federation of patient organizations and people active in rare diseases was recently accepted by the EURODIS Board of Directors. By becoming a member of EURORDIS, The SSRA reaffirms its commitment to provide research support to all superficial siderosis patients, no matter where they may currently reside. Due […]

The SSRA Marks Our Second Year

The Superficial Siderosis Research Alliance celebrates its 2nd anniversary on September 24, 2021 Since its inception in 2019, the SSRA has been honored to represent the superficial siderosis rare disorder community. Battling a rare disorder is difficult, but patients and caregivers are no longer alone in this fight with the Superficial Siderosis Research Alliance (SSRA). This past year the SSRA […]

The World of Digital Awareness

Sharing Our Rare Disorder Journey As part of our awareness campaign this September, our SS community members from around the world joined together to create a footprint in the world of digital awareness. This short video is available for viewing on several social media platforms and offers a unique window into the superficial siderosis patient rare disorder journey. When you […]

Round-Up For Research

Round Up For Research To spread awareness during September Superficial Siderosis month, Caffe’ Crema owners Tanya and Greg Beers have added a “ROUND-UP FOR RESEARCH” option to their online ordering app and in-store sales. Customers will be given an option of rounding up their purchase to the nearest whole dollar for donation to the SSRA. They also can bump their […]

Superficial Siderosis Awareness Month is Here

Superficial Siderosis Awareness Month is Here September has arrived, and the SSRA regional directors are working overtime on our Superficial Siderosis Awareness month campaign. As a result, the education articles are hitting inboxes, our social media feeds are humming, and our advocates are stepping up to spread the word about Superficial Siderosis. One look at the efforts of our Rocky […]

Speeding Therapy Access Today

Removing Regulatory Roadblocks There are over 7,000 identified rare diseases and disorders in the world. While Superficial Siderosis may impact a small number of people, the Everylife Foundation believes a cumulative 30 million Americans are living with all these conditions. 93% to 95% have no FDA-approved treatments. While there are many reasons, research and regulatory challenges remain high on the […]